Celestica Inc. (NYSE: CLS) has priced a significant equity offering at $310 per share, raising approximately $3 billion to fuel its aggressive expansion into AI infrastructure. The transaction, announced early Thursday, represents a 14.5% discount to Wednesday's closing price of $362.76, triggering a sharp premarket selloff with shares trading around $311, down 14.3%.
The offering comprises 9.68 million newly issued shares, with underwriters holding an option to purchase an additional 1.45 million shares, which would bring total gross proceeds to $3.45 billion. This move increases the company's share count by 8.4% (or 9.7% with the full option), diluting existing shareholders by approximately 7.8% to 8.8%.
According to preliminary calculations, the weighted share increase could reduce 2026 adjusted earnings per share by 3.3% to 3.7%, before accounting for any benefits from the new capital. Celestica's current 2026 adjusted EPS guidance stands at $11.30, assuming no additional share issuance. The company has not revised this outlook.
The financing is substantial, equating to roughly five times the company's projected 2026 free cash flow. This underscores management's conviction in the AI infrastructure boom, but also sets a high bar: investment in inventory and manufacturing capacity must outpace dilution before 2027 to justify the move.
Celestica's balance sheet reveals the urgency behind the capital raise. Inventory surged 55.5% in the first half of 2026 to $3.40 billion, while accounts receivable grew 26.5% to $3.34 billion. Capital expenditures skyrocketed to $493.3 million, a 612.9% increase year-over-year, reflecting substantial investments in production capacity. Despite these outlays, the company generated $285 million in free cash flow during the period.
Management frames the offering as a strategic move to maintain financial flexibility. CFO Mandeep Chawla stated the capital will allow Celestica to "seamlessly scale alongside our customers' evolving multi-year capital deployment plans," while CEO Rob Mionis highlighted record demand. The company had $740 million in term loans and access to $1.74 billion via its revolving credit facility, making this equity raise a choice to preserve leverage rather than a necessity.
Operationally, Celestica is firing on all cylinders. Second-quarter revenue surged 62% year-over-year to $4.70 billion, driven by an 84% jump in Connectivity and Cloud Solutions revenue to $3.81 billion. Adjusted operating margin expanded to 8.2% from 7.4%, and adjusted EPS nearly doubled to $2.54. The company's 2026 outlook calls for revenue of $20.5 billion (up 65%) and adjusted EPS of $11.30 (up 87%).
Looking ahead to 2027, management expects revenue growth to exceed 65%, which would imply sales of at least $33.8 billion based on the 2026 forecast. Analyst targets set after the Q2 report remain well above the offering price, with Stifel at $500, JPMorgan at $485, and Wolfe Research at $475, suggesting optimism persists despite near-term dilution.
However, the market's reaction highlights investor caution. The stock has pulled back 6.2% from last Friday's close. Key support at $310 will be closely watched in the coming days. Risks include potential delays in program ramps, supply chain constraints, and infrastructure limitations such as power or water availability for data centers. The offering is expected to close on August 7.
For existing shareholders, the calculus is clear: short-term dilution in exchange for a potentially larger earnings base in 2027. The execution gap between now and then will determine whether this bold move pays off.
